RJA
PBYI icon

Raymond James & Associates’s Puma Biotechnology PBYI Stock Holding History

Raymond James & Associates’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-11,000
Closed -$111K – 3848
2020
Q3 		$111K Buy
+11,000
New +$112K ﹤0.01% 3364
2018
Q3 		– Sell
-7,693
Closed -$455K – 3695
2018
Q2 		$455K Buy
7,693
+3,303
+75% +$191K ﹤0.01% 2744
2018
Q1 		$299K Buy
4,390
+140
+3% +$10.5K ﹤0.01% 2881
2017
Q4 		$420K Buy
+4,250
New +$476K ﹤0.01% 2640
2016
Q4 		– Sell
-23,078
Closed -$1.55M – 3330
2016
Q3 		$1.55M Buy
+23,078
New +$1.17M ﹤0.01% 1616

Other funds holding PBYI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return